Dostarlimab
Product Specifications
CAS Number
2022215-59-2
Target
PD-1/PD-L1
Related Pathways
Cell Cycle/Checkpoint, Apoptosis, Immunology/Inflammation
Purity
0.9892
Bioactivity
Dostarlimab (TSR-042) is a programmed cell death protein 1 (PD-1) receptor immune checkpoint inhibitor that blocks interactions with PD-L1 and PD-L2, used in the study of endometrial cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15099810 1 Vial
Lentiviral human SPDYA shRNA (UAS) - Lentiviral human SPDYA shRNA (UAS) (100)
Sign In for Pricing
View Details